ArticleCureus2024
Relationship of Biochemical and Hematological Markers With Alcohol Withdrawal Severity.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Alcohol withdrawal severity is widely assessed and objectified using the Clinical Institute Withdrawal Assessment for Alcohol revised (CIWA-Ar) scale. However, the subjective nature of this scale has led to several studies that scrutinized the relationship of various blood parameters to assess withdrawal severity. The aim of this study was to analyze the relationship of various laboratory biomarkers with the severity of alcohol withdrawal. Methods This was a retrospective study of 200 cases admitted to Rashid Hospital, UAE, with the diagnosis of alcohol withdrawal syndrome. Severity was assessed using CIWA-Ar. The average CIWA-Ar score was calculated and analyzed against creatine phosphokinase (CPK) on admission days one, two, and three using a correlation coefficient. Sixteen other blood markers were also analyzed, including hemoglobin, mean corpuscular volume, white blood cell (WBC), platelets, alanine transaminase, aspartate aminotransferase, aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio, gamma-glutamyl transferase, albumin, international normalized ratio, lactate dehydrogenase, sodium, potassium, magnesium, phosphate, and creatinine. Additionally, the duration of alcohol intake and the timing of the last alcohol intake were also examined in relation to the severity of alcohol withdrawal. Results Average CIWA-Ar exhibited a positive relationship with CPK on admission day one (r=0.2 (p=0.008)); day two (r= 0.25 (p=0.003)), and day three (r=0.42 (p<0.001)). WBC and AST showed a relatively rising trend with higher CIWA scores (average values, however, remain within the normal range). The results were not statistically significant (p>0.01). Serum potassium and magnesium levels followed a decreasing trend with rising CIWA (average values, however, remained within the normal range). These results were also not found to be statistically significant (p>0.1). Conclusion A high CPK level was associated with the severity of alcohol withdrawal syndrome (SAWS). Low serum potassium and magnesium and high WBC and AST can be associated with alcohol withdrawal severity. These routine laboratory tests can serve as objective indicators of severity in addition to using the CIWA-Ar score for AWS, enabling prompt management and prevention of complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.